Condition: Hepatocellular Carcinoma (HCC) · Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CT imaging data and MR imaging data from liver cancer (hepatocellular carcinoma) patients prior to the initiation of immunotherapy (and possibly also after treatment) will be collected. The processing pipeline includes automatic tumor segmentation, radiomics feature extraction, feature selection, and construction of a classification model.
This description comes directly from the study's public registry record.
Lian Yang · 18986273791 · yanglian@hust.edu.cn
Always discuss trial participation with your own doctor first.
| Union Hospital，Tongji Medical College，Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07059936